Seeking AlphaWed, 24 Jun 2026 18:02:08 GMTGalectin De-Risks Belapectin Path With FDA Alignment - Sets Stage For Phase 3 UpsideGALT+6.35%
Zacks Investment ResearchWed, 24 Jun 2026 15:06:03 GMTGALT Jumps 11% on FDA Alignment for Belapectin Phase III Path in MASHGALT+6.35%
Zacks Investment ResearchFri, 03 Apr 2026 17:01:15 GMTGalectin Therapeutics (GALT) Upgraded to Buy: What Does It Mean for the Stock?GALT+6.35%
